AFP and metabolic dysfunction-associated steatotic liver disease: Other risk factors included poor tumor differentiation, absence of tumor encapsulation, hepatic capsule invasion, microvascular invasion, macrovascular invasion, deviation from Milan criteria, post-transplant MAFLD and NAFLD, elevated levels of pre- and post-transplant alpha-fetoprotein, NLR, and decreased post-transplant lymphocyte percentage.